EHTH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
eHealth Inc (EHTH) is not a good buy for a beginner, long-term investor at this time. The stock is facing significant challenges, including bearish technical indicators, weak analyst sentiment, and declining financial performance. Additionally, hedge funds are selling, and there are no positive catalysts or trading signals to support a buy decision. It is advisable to wait for clearer signs of recovery or improvement in the company's fundamentals before considering investment.
The technical indicators for EHTH are bearish. The MACD histogram is positive but contracting, the RSI is neutral at 41.709, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 1.456 and S2 at 1.387, suggesting further downside potential.
NULL identified. There is no recent news or significant positive developments for the company.
Analysts have significantly lowered price targets and downgraded the stock due to weak guidance and challenging market conditions.
Hedge funds are aggressively selling, with a 1442.15% increase in selling activity last quarter.
Financial performance shows declining net income (-13.72% YoY) and EPS (-17.01% YoY), despite a slight increase in revenue.
In Q4 2025, eHealth reported a 3.51% YoY increase in revenue to $326.24M. However, net income dropped by 13.72% YoY to $73.93M, and EPS declined by 17.01% YoY to 2.39. Gross margin improved slightly by 0.57% YoY to 100, but the overall financial performance indicates weakening profitability.
Analysts have a negative outlook on EHTH. RBC Capital, Deutsche Bank, and Craig-Hallum have all lowered price targets significantly, citing weak guidance, reduced marketing spend, and challenging market conditions. The current ratings are 'Hold' or 'Sector Perform,' reflecting a lack of confidence in the stock's near-term growth prospects.
